Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
boston blog main
drugs
life sciences
national blog main
new york blog main
new york top stories
2
×
akcea therapeutics
alirocumab
amgen
biotech
boston
boston top stories
clinical trials
european medicines agency
evercore isi
evolocumab
fda
harvard pilgrim health care
heart attack
hereditary transthyretin amyloidosis
inclisiran
inotersen
institute for clinical and economic review
joseph swartz
medicines co.
national top stories
new york
onpattro
patisiran
pcsk9 inhibitors
pfizer
regeneron pharmaceuticals
rna interference
san diego blog main
san diego top stories
stroke
svb leerink
tafamidis
umer raffat
What
alnylam
drug
2
×
rna
2
×
approves
based
cells
cholesterol
data
ema
employ
europe
evidence
fda
follows
gene
harmful
heart
hits
interference
lasting
long
looms
lowering
make
medco
medicine
medicines
method
mute
new
partner
pharmaceuticals
presented
protein
reckoning
rnai
supporting
term
touts
use
Language
Current search:
rna
×
" new york top stories "
×
drug
×
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug